Biochemistry, Genetics and Molecular Biology
DNA Damage Response
100%
DNA Repair
88%
DNA Damage
79%
Homologous Recombination
67%
Tumor Suppressor Protein
62%
Cancer Cell
54%
BRCA1
49%
Poly ADP Ribose Polymerase
47%
Genome Instability
46%
Recombination Repair
36%
P53
35%
Programmed Cell Death
33%
Immune Checkpoints
33%
Genomics
31%
Cell Proliferation
27%
DNA Synthesis
25%
Oncogene
22%
Epidermal Growth Factor Receptor
22%
Tumor Progression
22%
Gene Expression Profiling
21%
Cell Cycle
21%
Receptor Tyrosine Kinase
19%
Carcinogenesis
18%
Mouse Model
16%
Small Interfering RNA
15%
Helicase
15%
Protein Stability
14%
Fibroblast
13%
Tumor Necrosis Factor
13%
Cyclin E
13%
Tumor-Infiltrating Lymphocytes
13%
Chromatin Remodeling
13%
Catenin
13%
Immunity
13%
T Cell
13%
C-Terminus
13%
Ataxia Telangiectasia Mutated
13%
MDC1
12%
RAD51
12%
Tumor Suppressor Gene
11%
Ubiquitination
11%
Cell Survival
11%
Cell Cycle Checkpoint
11%
BRCA2
11%
Promoter Region
11%
Mitosis
10%
Telomerase
10%
Microcephalin
10%
Polymerase
10%
Tyrosine Kinase
10%
Keyphrases
Breast Cancer
67%
DNA Damage Response
34%
Immune Checkpoint Blockade
32%
Tumor
31%
DNA Repair
30%
DNA Damage
28%
BRIT1
28%
MCPH1
27%
PARP Inhibitor (PARPi)
24%
Tumor Suppressor
22%
Breast Cancer Cells
21%
Non-small Cell Lung Cancer (NSCLC)
20%
Overexpression
18%
Triple-negative Breast Cancer
16%
Tumor Suppression
16%
Tumor-infiltrating Lymphocytes
14%
Cytosolic DNA
14%
Cyclin E
13%
Catenin
13%
Genome Maintenance
13%
Tumor Necrosis Factor-α
13%
Synergize
13%
Replication Stress Response
13%
Induced Apoptosis
13%
Genomic Instability
13%
In Cancer
13%
Cancer Development
12%
Small Interfering RNA (siRNA)
12%
Replication Stress
12%
Genome Stability
12%
Homologous Recombination Repair
11%
Tumor Microenvironment
11%
Protein Stability
10%
Stimulator of Interferon Genes (STING)
10%
NF-B
10%
Oncogene
10%
Tumor Progression
10%
Tumor Development
10%
Phosphorylation
10%
Epidermal Growth Factor Receptor
10%
Homologous Recombination DNA Repair
10%
Breast Cancer Susceptibility Gene 1 (BRCA1)
9%
Protein Function
9%
BRCA1, BRCA2
9%
Immune Checkpoint Therapy
9%
Tumor Cells
9%
Therapeutic Vulnerabilities
9%
Tyrosine Kinase
9%
Overexpressing
9%
Homologous Recombination Defect
8%
Medicine and Dentistry
Neoplasm
57%
Breast Cancer
50%
Immune Checkpoint Blockade
32%
DNA Repair
23%
Cylindroma
20%
Cancer Cell
20%
DNA Damage Response
18%
Homologous Recombination
17%
Poly ADP Ribose Polymerase
15%
PARP Inhibitor
15%
Malignant Neoplasm
15%
Carcinogenesis
15%
Programmed Cell Death
14%
Tumor Microenvironment
14%
Tumor Necrosis Factor
13%
Genomic Instability
12%
Cancer
10%
BRCA1
10%
Cancer Therapy
9%
Triple Negative Breast Cancer
8%
Biological Marker
8%
Estrogen Receptor
8%
Immunotherapy
8%
MEK Inhibitor
8%
Immunogenicity
8%
Recombination Repair
8%
Immunity
8%
Tumor Cell
7%
DNA Synthesis
7%
Protein P53
7%
Cancer Inhibition
7%
Combination Therapy
7%
Promoter Region
7%
Salivary Adenoid Cystic Carcinoma
6%
Personalized Medicine
6%
Isograft
6%
4 Iodo 2,5 Dimethoxyamphetamine
6%
Drug Delivery System
6%
Base Excision Repair
6%
COVID-19 Vaccine
6%
Chloride Channel
6%
DNA Topoisomerase (ATP Hydrolysing)
6%
Sensitization
6%
Dormancy
6%
Protein Kinase B
6%
Single Stranded DNA
6%
Kidney Carcinoma
6%
Interferon
6%
Hepatocellular Carcinoma
6%
Tumor Regression
6%
